Can We Beat Cancer? AI, mRNA, and the Future of Living Longer | Longevity, Episode 2

In the second episode of this four-part series, Rubenstein delved into the breakthroughs in cancer detection and treatment, how artificial intelligence could transform prevention and early diagnosis, why cancer rates are rising among young adults, the role of mRNA vaccines in preventing and treating future cancers and the urgent challenges of health disparities and access to care.

Guests include:
Dr. Selwyn M. Vickers | Memorial Sloan Kettering Cancer Center President & CEO
Dr. Benjamin L. Ebert | Dana-Farber Cancer Institute President and CEO
Dr. David Agus | Ellison Medical Institute Founding CEO
Dr. Elizabeth Jaffee | Johns Hopkins Kimmel Cancer Center Deputy Director

Chapters:
00:02:23 - What is Cancer?
00:04:23 - Stages of Cancer
00:09:21 - Cancer Prevention and Treatment
00:19:34 - Screening Data

Disclosure
David Rubenstein is a Trustee of Memorial Sloan Kettering Cancer Center
David Rubenstein is a Director of Moderna, Inc.
David Rubenstein is a Trustee Emeritus of Johns Hopkins Medicine


--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
/ @davidrubenstein

Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
https://www.bloomberg.com/peer-to-peer

Learn more about David:
http://www.davidrubenstein.com/
Connect with us on...
Twitter: / business
Facebook: / bloombergbusiness
Instagram: / bloombergbusiness